Sonoma Pharmaceuticals (SNOA) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart

Sonoma Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$12.73M

Latest Revenue (Q)

$5.60M

Main Segment (Y)

Human Care

Main Geography (Y)

Service

Sonoma Pharmaceuticals Revenue by Period

Sonoma Pharmaceuticals Revenue by Year

Date	Revenue	Change
2024-03-31	$12.73M	-4.05%
2023-03-31	$13.27M	5.10%
2022-03-31	$12.63M	-32.21%
2021-03-31	$18.63M	-1.62%
2020-03-31	$18.94M	-0.18%
2019-03-31	$18.97M	13.88%
2018-03-31	$16.66M	29.89%
2017-03-31	$12.82M	-14.98%
2016-03-31	$15.08M	8.88%
2015-03-31	$13.85M	1.36%
2014-03-31	$13.67M	-11.55%
2013-03-31	$15.45M	21.25%
2012-03-31	$12.74M	30.65%
2011-03-31	$9.75M	32.46%
2010-03-31	$7.36M	36.67%
2009-03-31	$5.39M	40.50%
2008-03-31	$3.83M	-15.58%
2007-03-31	$4.54M	75.81%
2006-03-31	$2.58M	90.56%
2005-03-31	$1.36M	50.33%
2004-03-31	$902.00K	-63.48%
2003-03-31	$2.47M	23.50%
2002-03-31	$2.00M	-

Sonoma Pharmaceuticals generated $12.73M in revenue during NA 2024, up -4.05% compared to the previous quarter, and up 67.13% compared to the same period a year ago.

Sonoma Pharmaceuticals Revenue by Quarter

Date	Revenue	Change
2025-09-30	$5.60M	39.58%
2025-06-30	$4.01M	6.95%
2025-03-31	$3.75M	5.33%
2024-12-31	$3.56M	-0.42%
2024-09-30	$3.58M	5.54%
2024-06-30	$3.39M	-1.40%
2024-03-31	$3.44M	9.59%
2023-12-31	$3.14M	14.90%
2023-09-30	$2.73M	-20.31%
2023-06-30	$3.43M	13.70%
2023-03-31	$3.01M	2.38%
2022-12-31	$2.94M	-11.62%
2022-09-30	$3.33M	-16.37%
2022-06-30	$3.98M	73.32%
2022-03-31	$2.30M	-20.81%
2021-12-31	$2.90M	-22.49%
2021-09-30	$3.74M	1.63%
2021-06-30	$3.68M	70.79%
2021-03-31	$2.16M	-56.30%
2020-12-31	$4.94M	-14.44%
2020-09-30	$5.77M	0.03%
2020-06-30	$5.77M	33.74%
2020-03-31	$4.31M	-1.89%
2019-12-31	$4.39M	-7.02%
2019-09-30	$4.73M	5.16%
2019-06-30	$4.50M	2.58%
2019-03-31	$4.38M	-17.01%
2018-12-31	$5.28M	6.90%
2018-09-30	$4.94M	13.05%
2018-06-30	$4.37M	19.53%
2018-03-31	$3.65M	-24.53%
2017-12-31	$4.84M	11.98%
2017-09-30	$4.33M	12.78%
2017-06-30	$3.83M	-4.82%
2017-03-31	$4.03M	19.88%
2016-12-31	$3.36M	-18.18%
2016-09-30	$4.11M	7.79%
2016-06-30	$3.81M	7.96%
2016-03-31	$3.53M	-7.59%
2015-12-31	$3.82M	-5.77%
2015-09-30	$4.05M	10.16%
2015-06-30	$3.68M	-7.54%
2015-03-31	$3.98M	23.68%
2014-12-31	$3.22M	-1.41%
2014-09-30	$3.26M	-3.77%
2014-06-30	$3.39M	16.40%
2014-03-31	$2.91M	-11.51%
2013-12-31	$3.29M	-19.47%
2013-09-30	$4.09M	21.26%
2013-06-30	$3.37M	1.11%
2013-03-31	$3.33M	-5.79%
2012-12-31	$3.54M	-21.79%
2012-09-30	$4.53M	11.73%
2012-06-30	$4.05M	20.89%
2012-03-31	$3.35M	20.11%
2011-12-31	$2.79M	-23.83%
2011-09-30	$3.66M	24.59%
2011-06-30	$2.94M	8.45%
2011-03-31	$2.71M	17.21%
2010-12-31	$2.31M	-6.20%
2010-09-30	$2.47M	8.92%
2010-06-30	$2.26M	1.43%
2010-03-31	$2.23M	38.38%
2009-12-31	$1.61M	-3.53%
2009-09-30	$1.67M	-9.47%
2009-06-30	$1.85M	25.22%
2009-03-31	$1.48M	20.80%
2008-12-31	$1.22M	-17.56%
2008-09-30	$1.48M	22.30%
2008-06-30	$1.21M	30.78%
2008-03-31	$926.00K	-13.13%
2007-12-31	$1.07M	-

Sonoma Pharmaceuticals generated $5.60M in revenue during Q2 2026, up 39.58% compared to the previous quarter, and up 165.26% compared to the same period a year ago.

Sonoma Pharmaceuticals Revenue Breakdown

Sonoma Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Human Care	$12.08M	$10.11M	-	-	-
Animal Care	$1.65M	$2.20M	-	-	-
Service And Royalty	$556.00K	$422.00K	-	-	-
Shipping and Handling	-	-	$42.00K	$52.00K	$37.00K
Service	-	-	-	$349.00K	$112.00K

Sonoma Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Mar 25: Human Care (84.54%), Animal Care (11.57%), and Service And Royalty (3.89%).

Quarterly Revenue by Product

Product/Service	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Dec 20	Sep 20	Jun 20	Mar 20
Animal Care	$488.00K	$875.00K	$376.00K	$402.00K	$1.09M	$621.00K	$489.00K	$414.00K	$818.00K	$1.00M	$812.00K	$1.36M	$951.00K	$377.00K	-	-	-	-	-	-
Human Care	$5.12M	$6.07M	$3.05M	$2.96M	$5.57M	$2.46M	$2.08M	$1.81M	$2.02M	$2.59M	$2.71M	$3.53M	$4.78M	$6.86M	-	-	-	-	-	-
Product	-	$4.01M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service And Royalty	-	-	$200.00K	$136.00K	$220.00K	$199.00K	$56.00K	$167.00K	$69.00K	$148.00K	$157.00K	-	-	-	-	-	-	-	-	-
Service	-	-	-	-	-	-	-	-	$99.00K	$75.00K	$147.00K	$1.03M	$280.00K	-	-	-	-	-	-	-
Other Sales	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$45.00K	$42.00K	$13.00K	-

Sonoma Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Human Care (91.29%), and Animal Care (8.71%).

Sonoma Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 22
Shipping and Handling	$52.00K
Service	$349.00K

Sonoma Pharmaceuticals's latest annual revenue breakdown by geography, as of Mar 22: Service (87.03%), and Shipping and Handling (12.97%).

Quarterly Revenue by Country

Country	Dec 20	Sep 20	Jun 20
Europe and Rest of the World	$1.65M	$1.76M	$3.21M
UNITED STATES	$1.98M	$1.98M	$1.72M
Latin America	$1.31M	$2.02M	$2.32M

Sonoma Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 20: UNITED STATES (40.07%), Europe and Rest of the World (33.45%), and Latin America (26.48%).

Sonoma Pharmaceuticals Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
EVOK	Evoke Pharma	$10.25T	$4.28M
FLGC	Flora Growth	$59.51M	$14.80M
BFRI	Biofrontera	$37.30M	$6.99M
SNOA	Sonoma Pharmaceuticals	$12.73M	$5.60M
MYNZ	Mainz Biomed B.V.	$895.48K	$214.76K
RADX	Radiopharm Theranostics	$299.23K	-
TCRT	Alaunos Therapeutics	$10.00K	-
QNRX	Quoin Pharmaceuticals	-	-

SNOA Revenue FAQ

What is Sonoma Pharmaceuticals’s yearly revenue?

Sonoma Pharmaceuticals's yearly revenue for 2024 was $12.74M, representing a decrease of -4.05% compared to 2023. The company's yearly revenue for 2023 was $13.27M, representing an increase of 5.10% compared to 2022. SNOA's yearly revenue for 2022 was $12.63M, representing a decrease of -32.21% compared to 2021.

What is Sonoma Pharmaceuticals’s quarterly revenue?

Sonoma Pharmaceuticals's quarterly revenue for Q2 2026 was $5.6M, a 39.58% increase from the previous quarter (Q1 2026), and a 56.58% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $4.02M, a 6.95% increase from the previous quarter (Q4 2025), and a 18.40% increase year-over-year (Q1 2025). SNOA's quarterly revenue for Q4 2025 was $3.75M, a 5.33% increase from the previous quarter (Q3 2025), and a 9.16% increase year-over-year (Q4 2024).

What is Sonoma Pharmaceuticals’s revenue growth rate?

Sonoma Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0.85%, and for the last 5 years (2020-2024) was -32.75%.

What are Sonoma Pharmaceuticals’s revenue streams?

Sonoma Pharmaceuticals's revenue streams in r 25 are Human Care, Animal Care, and Service And Royalty. Human Care generated $12.08M in revenue, accounting 84.54% of the company's total revenue, up 19.48% year-over-year. Animal Care generated $1.65M in revenue, accounting 11.57% of the company's total revenue, down -24.97% year-over-year. Service And Royalty generated $556K in revenue, accounting 3.89% of the company's total revenue, up 31.75% year-over-year.

What is Sonoma Pharmaceuticals’s main source of revenue?

For the fiscal year ending Mar 25, the largest source of revenue of Sonoma Pharmaceuticals was Human Care. This segment made a revenue of $12.08M, representing 84.54% of the company's total revenue.